Literature DB >> 28042130

Pregnancy Outcomes in Patients with Psoriatic Arthritis.

Maria A Mouyis1, Catherine C Thornton2, David Williams3, Ian P Giles4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28042130     DOI： 10.3899/jrheum.160929

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

1.  Reproductive health outcomes in women with psoriatic arthritis.

Authors:  Kieran Murray; Louise Moore; Fionnuala McAuliffe; Douglas J Veale
Journal:  Ann Rheum Dis       Date:  2019-02-15       Impact factor: 19.103

2.  Birth Outcomes and Disease Activity During Pregnancy in a Prospective Cohort of Women With Psoriatic Arthritis and Ankylosing Spondylitis.

Authors:  Chelsey J F Smith; Gretchen Bandoli; Arthur Kavanaugh; Christina D Chambers
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-06-11       Impact factor: 4.794

3.  Sleep Disturbances and Modulations in Inflammation: Implications for Pregnancy Health.

Authors:  Michele L Okun
Journal:  Soc Personal Psychol Compass       Date:  2019-04-11

4.  Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare.

Authors:  Kenneth D Allen; Miranda K Kiefer; Madalina Butnariu; Anita Afzali
Journal:  Arch Gynecol Obstet       Date:  2022-03-06       Impact factor: 2.344

5.  Pregnancy outcomes, fertility, and family planning in women with psoriatic arthritis.

Authors:  Amanda M Eudy; Gary McDaniel; Megan Eb Clowse
Journal:  Obstet Med       Date:  2019-01-31

6.  Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.

Authors:  Xavier Mariette; Frauke Förger; Bincy Abraham; Ann D Flynn; Anna Moltó; René-Marc Flipo; Astrid van Tubergen; Laura Shaughnessy; Jeff Simpson; Marie Teil; Eric Helmer; Maggie Wang; Eliza F Chakravarty
Journal:  Ann Rheum Dis       Date:  2017-10-13       Impact factor: 19.103

7.  Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.

Authors:  Megan E B Clowse; Angela E Scheuerle; Christina Chambers; Anita Afzali; Alexa B Kimball; John J Cush; Maureen Cooney; Laura Shaughnessy; Mark Vanderkelen; Frauke Förger
Journal:  Arthritis Rheumatol       Date:  2018-07-22       Impact factor: 10.995
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.